With a market cap of $190.2 billion, Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and sells a wide range of products across pharmaceuticals, diagnostics, nutrition, and medical devices. It provides innovative healthcare solutions including generic medicines, diagnostic systems, nutritional products, cardiovascular devices, and diabetes care technologies worldwide.
Shares of the Abbott Park, Illinois-based company have underperformed the broader market over the past 52 weeks. ABT stock has decreased 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 12.2%. Moreover, the stock has declined 11.8% on a YTD basis, compared to SPX's 10.3% rise.